Recombinant IL17A, IL17F (Afasevikumab Biosimilar) antibody

Catalog No. ABIN7597495

The Human Monoclonal anti-IL17A, IL17F (Afasevikumab Biosimilar) antibody is suitable to detect IL17A, IL17F (Afasevikumab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL17A, IL17F (Afasevikumab Biosimilar) antibody (ABIN7597495)

Target: IL17A, IL17F (Afasevikumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL17A, IL17F (Afasevikumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL17A, IL17F (Afasevikumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Afasevikumab Biosimilar Antibody

Specificity: CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, IL17F, Interleukin-17F, IL-17F, Cytokine ML-1

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IL17A, IL17F (Afasevikumab Biosimilar)

Target: IL17A, IL17F (Afasevikumab Biosimilar)

Alternative Name: Afasevikumab Biosimilar

Target Type: Biosimilar

Background: CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, IL17F, Interleukin-17F, IL-17F, Cytokine ML-1

UniProt: Q16552, Q96PD4

CAS-No: 1589503-30-9